The TEAE reported as drug-induced liver injury consisted of asymptomatic elevations in ALT (14.1 × ULN) and AST (9.5 × ULN) in a participant with obesity (BMI: 32 kg/m2) and nonalcoholic steatohepatitis; ALT/AST levels normalized after treatment discontinuation. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.